Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiviral cyclic peptides targeting the main protease of SARS-CoV-2. | Chem Sci | 2022 | 35432913 | PubTator, text mining | PubMed |
| Molecular docking-assisted investigation of Pd(II) complexes carrying "SNS" pincer-type pyridine-thioether ligand as potential drug candidates against COVID-19. | Comput Biol Med | 2022 | 35429834 | PubTator, text mining | PubMed |
| Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients. | J Transl Med | 2022 | 35428263 | PubTator, text mining | PubMed |
| Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro. | RSC Adv | 2022 | 35425393 | PubTator, text mining | PubMed |
| Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches. | RSC Adv | 2022 | 35424688 | PubTator, text mining | PubMed |
| Translational Control of COVID-19 and Its Therapeutic Implication. | Front Immunol | 2022 | 35422818 | PubTator, text mining | PubMed |
| Coding-Complete Sequence of a SARS-CoV-2 Strain from an Omicron (B.1.1.529+BA.1) Variant Detected in Morocco. | Microbiol Resour Announc | 2022 | 35420465 | PubTator, text mining | PubMed |
| Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach. | J Genet Eng Biotechnol | 2022 | 35420322 | PubTator, text mining | PubMed |
| Implementing a user-friendly format to analyze PRRSV next-generation sequencing results and associating breeding herd production performance with number of PRRSV strains and recombination events. | Transbound Emerg Dis | 2022 | 35416426 | PubTator, text mining | PubMed |
| Replication of the coronavirus genome: A paradox among positive-strand RNA viruses. | J Biol Chem | 2022 | 35413290 | PubTator, text mining | PubMed |
| Swine Enteric Coronavirus: Diverse Pathogen-Host Interactions. | Int J Mol Sci | 2022 | 35409315 | PubTator, text mining | PubMed |
| Host and Viral Zinc-Finger Proteins in COVID-19. | Int J Mol Sci | 2022 | 35409070 | PubTator, text mining | PubMed |
| Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern. | EBioMedicine | 2022 | 35405385 | PubTator, text mining | PubMed |
| EGCG Restricts PRRSV Proliferation by Disturbing Lipid Metabolism. | Microbiol Spectr | 2022 | 35404086 | PubTator, text mining | PubMed |
| SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond. | Front Cell Infect Microbiol | 2022 | 35402302 | PubTator, text mining | PubMed |
| The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh. | Gene Rep | 2022 | 35399222 | PubTator, text mining | PubMed |
| Spike protein of SARS-CoV-2 variants: a brief review and practical implications. | Braz J Microbiol | 2022 | 35397075 | PubTator, text mining | PubMed |
| Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. | Nat Commun | 2022 | 35393402 | PubTator, text mining | PubMed |
| SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. | J Virol | 2022 | 35389264 | PubTator, text mining | PubMed |
| Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection. | Bioengineered | 2022 | 35387556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=55